Printer Friendly

Price Tag Panic.

BLOCKBUSTER DRUG TAXOL, PRESCRIBED FOR LUNG, ovarian and breast cancer, as well as AIDS-related Kaposi's sarcoma, earned its manufacturer US$1.5 billion annually. But Bristol Myers-Squibb recently lost the patent, sparking a pricing scramble.

This year, not only is generic drug maker IVAX gearing up to produce a generic form of Taxol in the United States, there is also talk of allowing drug imports. These include brand name drugs produced by U.S. companies but sold at heavily discounted prices in Latin America.

Drug companies say that's bad news for their well-funded research and development programs. But patients and insurance companies herald the potential price tag relief.
 Price of Taxol (100 mg)
SOURCE: Bristol-Myers Squibb
COPYRIGHT 2001 Freedom Magazines, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Author:Estevez, Matthew
Publication:Latin Trade
Date:Feb 1, 2001
Previous Article:In Spite of Everything.
Next Article:Band-Aid?

Related Articles
A direct approach.
A patient with ear pain who had panic attacks while driving over bridges and in wide-open spaces. (Vestibulology Clinic).
Fears grow over RFID tag security unwarranted.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |